KBroVet®
(potassium bromide chewable tablets)
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
See full prescribing information for complete dosing and administration instructions.
| Item # | Product Name | Supplied |
|---|---|---|
| 30039748 | KBroVet® 250 mg Chewable Tablets | 60 ct. bottle |
| 30039750 | KBroVet® 250 mg Chewable Tablets | 180 ct. bottle |
| 30039848 | KBroVet® 500 mg Chewable Tablets | 60 ct. bottle |
| 30039850 | KBroVet® 500 mg Chewable Tablets | 180 ct. bottle |
Active Ingredient(s): potassium bromide
Important Safety Information: The most commonly reported side effects with KBr are increased appetite, weight gain, vommiting/regurgitation and sendaton. In dogs, ataxia; diarrhea; hematochezia; excessive salivation; shivering; skin lesions; stupor progressing to coma and death have been reported with a dose of 200 to 500mg/kg a day for 4 to 26 weeks. Adversse evenst associated with concurrent use of KBr with other antiepileptic drugs such as phenobarbital have been reported.
Dogs receiving KBr should be carefully monitored when changing diets, adminisering chlorid-containing IV fluids, and administering concurrent medications. Careful monitoring is important in dogs that have a condition that may cause diffifulty maintaining electolyte balance. Animals with decreased renal function may be predisposed to bromide toxicosis.
The safe use of KBroVet-CA1 has not been evaluated in dogs that are intended for breeding, or that are pregnant or lactating. The safe use of KBr in neonates and young animals has not been established. Reproductive effects of KBr have been reported in other species.
Warnings: Not for use in humans. Keep out of reach of children. Contact a physician in case of accidental ingestion by humans. Not for use in cats. Keep KBroVet-CA1 in a secured location out of reach of dogs, cats, and other animal to prevent accidental ingestion or overdose.
